oxaliplatin
Generic: oxaliplatin
Labeler: winthrop u.s, a business of sanofi-aventis u.s. llcDrug Facts
Product Profile
Brand Name
oxaliplatin
Generic Name
oxaliplatin
Labeler
winthrop u.s, a business of sanofi-aventis u.s. llc
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Routes
Active Ingredients
oxaliplatin 5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0955-1733
Product ID
0955-1733_0bef8406-8dab-0ad0-e063-6394a90a60d0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA AUTHORIZED GENERIC
Application Number
NDA021759
Listing Expiration
2026-12-31
Marketing Start
2015-09-01
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
09551733
Hyphenated Format
0955-1733
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oxaliplatin (source: ndc)
Generic Name
oxaliplatin (source: ndc)
Application Number
NDA021759 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/mL
Packaging
- 1 VIAL, GLASS in 1 CARTON (0955-1733-20) / 20 mL in 1 VIAL, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0bef8406-8dab-0ad0-e063-6394a90a60d0", "openfda": {"nui": ["N0000175413", "N0000175073"], "unii": ["04ZR38536J"], "rxcui": ["1736776", "1736781"], "spl_set_id": ["70269278-fe61-4800-a064-32cb6845cc28"], "pharm_class_epc": ["Platinum-based Drug [EPC]"], "manufacturer_name": ["Winthrop U.S, a business of sanofi-aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (0955-1733-20) / 20 mL in 1 VIAL, GLASS", "package_ndc": "0955-1733-20", "marketing_start_date": "20150901"}], "brand_name": "OXALIPLATIN", "product_id": "0955-1733_0bef8406-8dab-0ad0-e063-6394a90a60d0", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Platinum-based Drug [EPC]", "Platinum-containing Compounds [EXT]"], "product_ndc": "0955-1733", "generic_name": "oxaliplatin", "labeler_name": "Winthrop U.S, a business of sanofi-aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXALIPLATIN", "active_ingredients": [{"name": "OXALIPLATIN", "strength": "5 mg/mL"}], "application_number": "NDA021759", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20150901", "listing_expiration_date": "20261231"}